UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002311 |
|---|---|
| Receipt number | R000002820 |
| Scientific Title | Phase II prospective treatment study for IgG4+MOLPS |
| Date of disclosure of the study information | 2009/08/10 |
| Last modified on | 2018/08/16 11:46:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/08/09 15:32:25 | ||
| 2 | Update | 2009/08/18 15:39:29 | Key inclusion criteria |
|
| 3 | Update | 2010/08/12 16:26:31 | Recruitment status |
|
| 4 | Update | 2012/08/09 10:20:29 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2012/08/09 10:23:07 | Target sample size |
|
| 6 | Update | 2013/08/09 14:28:24 | Recruitment status |
|
| 7 | Update | 2014/08/09 09:47:31 | Publication of results |
|
| 8 | Update | 2015/02/09 09:43:43 | Email |
|
| 9 | Update | 2016/02/09 10:27:07 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 10 | Update | 2016/08/14 10:48:01 | Name of primary person or sponsor Institute Institute Organization Category of Funding Organization |
|
| 11 | Update | 2018/08/16 11:46:41 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results Results |
